Recent meaningful positive changes in investment behavior have benefitted GSK plc (NYSE: GSK): the stock’s recent price rise disrupted its longer term downtrend.
Recent notable positive changes in fundamentals have benefitted GSK plc (NYSE: GSK): the consensus estimate for December, 2023 increased significantly, significant quarterly sales acceleration occurred, and the consensus estimate for December, 2024 increased significantly.
In light of these very positive signals we are reviewing our current Overall Rating of D. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, GSK is expected to continue to be a major Value Builder.
GSK plc has a current Value Trend Rating of D (Negative). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. GSK plc has a very low Appreciation Score of 13 but a slightly positive Power Rating of 63, and the Negative Value Trend Rating results.
Recent Price Action
GSK plc (NYSE: GSK) stock closed at $36.57 on 12/1/23 after an increase of 1.6%. However, trading volume in this advance was below average at 72% of normal. The stock has risen 3.9% during the last week and has been strong relative to the market over the last nine months.
Be the first to comment